clinical trial · NCT07540494
Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects
GH Research Ireland Limited·phase1·not yet recruiting·n = 12
Healthy Adult5 Methoxy N,N DimethyltryptamineGH001 Aerosol Delivery System
brief summary
The primary objectives of this trial are to determine the pharmacokinetic (PK) profile and the safety and tolerability of GH001 delivered via a proprietary aerosol delivery device in healthy subjects after single-dose administration.
started
Apr 1, 2026
primary completion
May 1, 2026
completion
May 1, 2026
last updated
Apr 20, 2026
official title
An Open-label Phase 1 Trial to Determine the Pharmacokinetics, Pharmacodynamics and Safety of GH001 Administered Via a GH001 Aerosol Delivery System in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol